Plasminogen Activator System and Vascular Disease
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
101-116
Author(s):
Suzanne M. Nicholl, Elisa Roztocil and Mark G. Davies
Recombinant Antibodies in Cancer Therapy
Journal:
Current Protein & Peptide Science
Volume:
7
Page:
165-170
Author(s):
M. S. Nayeem and Rizwan H. Khan
Geminin as A Molecular Target for the Development of New Anticancer Drugs
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
461-462
Author(s):
Kenichi Yoshida
Cancer Pharmacogenetics: The Move from Pharmacokinetics to Pharmacodynamics
Journal:
Current Pharmacogenomics
Volume:
4
Page:
39-46
Author(s):
J. M. Hoskins and H. L. McLeod
Pharmacogenetics of Colon Cancer and Potential Implications for 5- Fluorouracil-Based Chemotherapy
Journal:
Current Pharmacogenomics
Volume:
4
Page:
57-67
Author(s):
R. Mauritz and G. J. Peters
Current Strategies for Modulating Lymphangiogenesis Signalling Pathways in Human Disease
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
783-792
Author(s):
S. A. Stacker, R. A. Hughes, R. A. Williams and M. G. Achen
Antagonists of Growth Hormone-Releasing Hormone in Oncology
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
9
Page:
163-170
Author(s):
Andrew V. Schally and Jozsef L. Varga
Implications of the Molecular Basis of Prostacyclin Biosynthesis and Signaling in Pharmaceutical Designs
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
925-941
Author(s):
Ke-He Ruan and Jean-Michel Dogne
Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
943-954
Author(s):
Makoto Murakami and Ichiro Kudo
Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
15-37
Author(s):
Kelly M. Swanson and Raymond J. Hohl